Sorrento Therapeutics Inc (SRNE): Don't hold your breath for SEMDEXA r...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	12
Posts	2336
Boards Moderated	0
Alias Born	04/20/2006

1776club

Re: None

Wednesday, 04/20/2022 2:24:28 AM

Wednesday, April 20, 2022 2:24:28 AM

Don't hold your breath for SEMDEXA revenue.
Path to FDA Approval:
• Fast Track granted in 2018.
• Apply for Breakthrough Therapy
Designation with the FDA in 1H2022.
• Request pre-NDA meeting with the FDA in
1H2022.
• File NDA and Priority Review by 1H2023.
• Target launch 2023.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM